TMO vs VTAK · P/E 24, rev $23.00B vs rev $1.5M
Thermo Fisher Scientific Inc (TMO) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
TMO currently screens at market cap $153.06B and trailing P/E 23.8. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the TMO and VTAK stock pages for the full models.
Not investment advice.